Journal article
No evidence for DNA methylation of von Hippel-Lindau ubiquitin ligase complex genes in breast cancer
KT Huang, A Dobrovic, SB Fox
Breast Cancer Research and Treatment | Published : 2010
Abstract
pVHL is the central component of an ubiquitin ligase complex that targets hypoxia-inducible factor 1α (HIF-1α) for proteasomal degradation. This complex includes four other genes, Cullin 2 (CUL2), elongin C (TCEB1), elongin B (TCEB2) and ring-box 1 (RBX1). VHL has previously been reported to be methylated in sporadic renal cell carcinoma. Since HIF-1α is frequently expressed in breast carcinomas, we evaluated DNA methylation as a possible mechanism of silencing one or more of the VHL complex genes. Methylation-specific high resolution melting (MS-HRM) was used to screen the proximal promoter CpG islands for methylation of the VHL ubiquitin ligase complex genes. We were unable to identify met..
View full abstractGrants
Funding Acknowledgements
This work is supported by the Victorian Breast Cancer Research Consortium, Australia, the Cancer Council of Victoria and the National Breast Cancer Foundation. We would like to thank Professor Adrian L. Harris, University of Oxford, UK for the kind donation of breast tumour DNA.